Company: EUDAW
Filing Date: 2025-10-03
Form Type: 6-K
Source: 0001493152-25-016863
Chunk: 1

Company: EUDA Health Holdings Ltd
Filing Date: 2025-10-03
Form: 6-K
Chunk 1
---
 has been $2.00 or higher for three consecutive trading days.

On October 2, 2025, the Company and the Purchaser entered into an amendment to the Letter Agreement (the “Amendment to the Letter Agreement”) pursuant to which the Purchaser agreed not to convert the remaining $162,500 of the August Note until after October 31, 2025 (the “Repayment Date”) and on the Repayment Date, may, at its option, convert the remaining $162,500 balance of the August Note into 81,250 ordinary shares at $2.00 per share, or request in writing that the Company repay the $162,500 in cash on or before November 17, 2025 (i.e., the tenth business day from the Repayment Date).

As previously disclosed, the Company does not intend to exercise its right to send Purchaser any additional put requests for the sale of additional Notes to the Purchaser under the terms of the Purchase Agreement.

The foregoing description of the Amendment to Letter Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment to Letter Agreement which is filed as Exhibit 1.1 to this Current Report, and incorporated by reference herein.

The foregoing description of the Letter Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Letter Agreement which is filed as Exhibit 1.1 to the Company’s Current Report dated September 22, 2025, and incorporated by reference herein. The foregoing descriptions of the Purchase Agreement and the Note do not purport to be complete and are qualified in their entirety by references to the full text of the Purchase Agreement and the Note, respectively, copies of which are filed as Exhibits 1.1 and 1.2, respectively, to the Company’s Current Report dated August 6, 2025, and incorporated by reference herein.

This Report on Form 6-K is incorporated by reference into the Company’s Registration Statement on Form F-3(File No. 333-282723) and the prospectus thereof and any prospectus supplements or amendments thereto.

| Exhibits |     |                                |
| 1.1      |     | Amendment to Letter Agreement. |

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto